Search results
Share price of Lupin rises as Nifty strengthens
The Economic Times· 10 hours agoThe stock hit a high price of Rs 1654.9 and low of Rs 1630.0 during the session. The return on equity (ROE) for the stock stood at 13.39 per cent. Traded...
Lupin shares rise 0.79 per cent in Tuesday's trading session - The Economic Times
The Economic Times· 1 day agoShares of Lupin Ltd. rose 0.79 per cent to Rs 1629.0 in Tuesday's trade as of 10:35AM (IST) even as...
Lupin loses appeal in EU court, will have to pay €40 mn fine in Perindopril case - CNBC TV18
CNBC TV18· 5 days agoThe European Court of Justice has upheld the European Commission’s decision to impose a fine of 40...
Lupin shares gain 1.77% as Sensex rises
The Economic Times· 5 days agoA total of 34,891 shares changed hands on the counter till 10:35AM (IST)
Stocks in news: Allied Blenders, Lupin, Tata Motors, Hero Moto, NMDC, KPI Green and Indian Bank
Business Today· 1 day agoStocks including Allied Blenders, Lupin, Tata Motors, NMDC, Hero Moto, KPI Green, Indian Bank and Patanjali and more may remain under spotlight before the opening bell on Tuesday, July 02.
Lupin fined 40 Million Euros by EU court for anti-competitive drug deal | India Infoline
India Infoline· 5 days agoLupin must pay 40 million euros plus accrued interest to the European Commission.
USFDA gives nod to Lupin’s generic formulation to treat eye condition
Financial Express· 6 days agoOlopatadine Hydrochloride Ophthalmic Solution USP (RLD Pataday) had an estimated annual sale of USD...
Stock market update: Nifty Pharma index advances 0.65%
The Economic Times· 3 hours agoThe Nifty Pharma index closed 0.65 per cent up at 19915.3.
European Court of Justice upholds 40 million Euro fine on Lupin | India Infoline
India Infoline· 5 days agoThe European Court of Justice confirmed the European Commission’s decision to impose a 40 million euro fine on Lupin Limited. This decision was made in connection with a patent ...
EU top court rejects Servier appeal against EU antitrust fine - ET LegalWorld
The Economic Times· 6 days agoEurope's top court on Thursday rejected French drugmaker Servier's appeal against a finding by EU antitrust regulators a decade ago that its pay-for-delay deals with generic rivals were anti-competitive.